TrialJournal of acquired immune deficiency syndromes (1999)2024

Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data.

Michelle L D'Antoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.